BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17895942)

  • 21. Current strategies for treating infants with severe bronchopulmonary dysplasia.
    Papoff P; Cerasaro C; Caresta E; Barbàra CS; Midulla F; Moretti C
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():15-20. PubMed ID: 23016612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventilatory strategies for the extremely premature infant.
    Greenough A; Premkumar M; Patel D
    Paediatr Anaesth; 2008 May; 18(5):371-7. PubMed ID: 18363629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids.
    Knoppert DC; Mackanjee HR
    Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Health status at the age of 5-7 years of preterm infants with and without bronchopulmonary dysplasia].
    Kwinta P; Tomasik T; Klimek M; Cichocka-Jarosz E; Lis G; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):21-6. PubMed ID: 19485251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal ventilatory strategies and surfactant to protect the preterm lungs.
    Ramanathan R
    Neonatology; 2008; 93(4):302-8. PubMed ID: 18525214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental patterns from 1 to 4 years of extremely preterm infants who required home oxygen therapy.
    Moon NM; Mohay HA; Gray PH
    Early Hum Dev; 2007 Apr; 83(4):209-16. PubMed ID: 16860947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.
    Smith VC; Zupancic JA; McCormick MC; Croen LA; Greene J; Escobar GJ; Richardson DK
    J Pediatr; 2004 Jun; 144(6):799-803. PubMed ID: 15192629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors for bronchopulmonary dysplasia in neonates with respiratory distress syndrome].
    Chen Y; Han YK; Ye ZZ; Lu GJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):15-8. PubMed ID: 17306069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic interstitial lung diseases in childhood: bronchopulmonary dysplasia and exogenous allergic alveolitis].
    Resch B; Eber E; Zach M
    Klin Padiatr; 1998; 210(5):331-9. PubMed ID: 9782475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte subpopulations in bronchopulmonary dysplasia.
    Ballabh P; Simm M; Kumari J; Krauss AN; Jain A; Auld PA; Cunningham-Rundles S
    Am J Perinatol; 2003 Nov; 20(8):465-75. PubMed ID: 14703595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome.
    Baraldi E; Carraro S; Filippone M
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S1-3. PubMed ID: 19793629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in bronchopulmonary dysplasia.
    Strueby L; Thébaud B
    Expert Rev Respir Med; 2014 Jun; 8(3):327-38. PubMed ID: 24666156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence and mortality of bronchopulmonary dysplasia].
    Figueras Aloy J; Molina González J; Vilanova Juanola JM; Jiménez González R
    An Esp Pediatr; 1991 Jun; 34(6):441-5. PubMed ID: 1929011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk of bronchopulmonary dysplasia: the importance of diuresis].
    Introvini P; Pagani G; Episcopi M; Magni LA
    Pediatr Med Chir; 1983; 5(6):579-82. PubMed ID: 6681063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice.
    Thomas W; Speer CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
    Kaempf JW; Campbell B; Brown A; Bowers K; Gallegos R; Goldsmith JP
    J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary outcomes in bronchopulmonary dysplasia.
    Bhandari A; Panitch HB
    Semin Perinatol; 2006 Aug; 30(4):219-26. PubMed ID: 16860162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.
    Walsh MC; Wilson-Costello D; Zadell A; Newman N; Fanaroff A
    J Perinatol; 2003 Sep; 23(6):451-6. PubMed ID: 13679930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.
    Van Meurs KP; Hintz SR; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Das A; Higgins RD; Stevenson DK
    J Perinatol; 2007 Jun; 27(6):347-52. PubMed ID: 17443204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.